Zydus Cadila has received USFDA’s final approval to sell generic diabetes drug
The US health regulator has provided its final approval to the drug firm Zydus Cadila for marketing anti-diabetic Glyburide tablets in the American market. Zydus...
Download Unicorn Signals App
Powered By EquityPandit
